Invesaro

Stocks CTA-PA Financial statements

Financial statements

EIDP, Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 9 fiscal years, taken from the XBRL data EIDP, Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2008FY2010FY2010FY2011FY2012FY2013FY2014FY2015FY2016
Revenue30,52926,10927,70033,68134,81228,99828,40625,13024,594
Cost of revenue21,26421,40017,64217,02315,11214,469
Gross profit12,41713,41211,35611,38310,01810,125
Research and development1,3931,3781,6031,9602,1232,0371,9581,8981,641
Selling, general and administrative3,5933,4402,9123,3105,8865,3424,8914,6154,319
Operating income3,3404,6135,8815,3695,3696,356
Interest expense376408590447464448377342370
Pre-tax income2,3912,1843,2603,8793,0882,5664,3132,5913,265
Income tax3814155156476163601,168696744
Income from continuing operations2,7243,1922,4472,1933,1351,8892,509
Net income to minority interests3142140251411612
Net income2,0071,7553,0313,5592,7554,8483,6251,9532,513
EBITDA4,8435,9937,4417,0826,9727,973
EPS, basic2.211.933.323.822.945.223.952.172.87
EPS, diluted2.201.923.283.772.915.183.922.162.85
Shares, basic (weighted)902904909928933926915894873
Shares, diluted (weighted)907909922941942933922900877
Dividend per share1.641.641.641.641.701.781.841.721.52

Balance sheet

FY2008FY2010FY2010FY2011FY2012FY2013FY2014FY2015FY2016
Cash and equivalents3,6454,0214,2633,5864,2848,9416,9105,3004,605
Short-term investments592,1162,5384331231451249061,362
Receivables5,1403,7954,1244,5984,0694,5753,6903,4353,610
Inventory5,6815,3805,9677,1957,5658,0426,7876,1405,673
Other current assets122151204206264398506
Total current assets15,31117,28819,05918,05821,31724,38426,08217,38717,117
Property, plant and equipment11,15411,09411,33913,41212,7419,94510,0089,7849,231
Goodwill2,1352,1372,6175,4134,6164,5154,3324,2484,180
Intangible assets2,7102,5522,7045,4135,1265,0964,5694,1443,664
Long-term investments112104
Other non-current assets4,0554,1008781,0129609491,0031,1161,815
Total assets36,20938,18540,41048,64349,85952,14250,49041,16639,964
Accounts payable3,1283,5424,3494,8164,8535,1803,7863,3983,705
Accrued liabilities4,4604,1884,6825,2975,9976,2195,5965,5804,662
Short-term debt2,0121,5061338171,2751,7211,4221,165429
Total current liabilities9,7109,3909,38911,18513,55213,36713,80510,3168,897
Long-term debt7,6389,52110,13311,71310,44110,7189,2217,6308,098
Other non-current liabilities11,16911,49011,02615,50814,68710,17913,61512,59112,333
Total liabilities28,65730,53430,66739,43039,56035,21337,11230,96629,768
Total debt7,63810,50210,13712,12311,69312,39210,6648,7458,102
Paid-in capital8,3808,4699,22710,10710,65511,07211,17411,08111,190
Retained earnings10,45610,71012,03013,42214,38316,78416,89414,51014,924
Treasury stock-6,727-6,727-6,727-6,727-6,727-6,727-6,727-6,727-6,727
Other comprehensive income-5,518-5,771-5,790-8,750-8,495-5,290-8,556-9,396-9,911
Shareholders' equity7,1257,2159,2788,59310,20816,22913,3209,9939,998
Minority interests427436465469915758207198
Total equity7,5527,6519,8009,20810,29916,28613,37810,20010,196
Total liabilities and equity36,20938,18540,41048,49249,85951,49950,49041,16639,964
Shares outstanding0

Cash flow statement

FY2008FY2010FY2010FY2011FY2012FY2013FY2014FY2015FY2016
Net income2,0101,7693,0523,5992,7804,8623,6361,9592,525
Depreciation and amortization1,1691,5031,3801,5601,7131,6031,6171,4661,258
Stock-based compensation112115108113105117136128119
Deferred income tax4373265-168-184-263255101
Change in inventory663481-512-1,018-812-519-318164-54
Change in payables-515-1151,0105281,037240-1,064-1,063-704
Cash from operations3,1294,7414,5595,1524,8493,1793,7122,3163,300
Capital expenditures-1,978-1,308-1,508-1,843-1,793-1,882-2,020-1,629-1,019
Acquisitions-144-13-637-6,459-18-1330-1520
Purchases of investments-650-497-936-1,897-2,633
Sales and maturities of investments9654529501,1212,181
Cash from investing-1,610-4,298-2,439-6,238-1,3462,945-337-1,828-1,514
Debt issued3,5273,6852,0612,5393232,0131043,679813
Debt repaid-547-1,977-2,859-1,163-916-1,312-1,794-1,537-1,440
Stock issued941708952550536327274181
Share buybacks0-250-672-400-1,000-2,000-2,353-916
Dividends paid-1,496-1,492-1,501-1,533-1,594-1,661-1,696-1,546-1,335
Cash from financing878-97-1,829403-2,697-1,474-5,074-1,823-2,328
Exchange rate effect-5730-496-13-88-332-275-153
Net change in cash2,340376242-6776984,562-2,031-1,610-695
Free cash flow1,1513,4333,0513,3093,0561,2971,6926872,281
Interest paid336403623455501489394341386
Income taxes paid609634165271,0541,3231,016885735

Key metrics

Worked out from the statements above. Latest values use fiscal 2016. Valuation uses the share price of $50.54 on September 28, 2026.

Profitability

MetricValueHow it is calculated
Gross margin41.2%Gross profit / revenue.
Pre-tax margin13.3%Pre-tax income / revenue.
Net margin10.2%Net income / revenue.
FCF margin9.3%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin13.4%Cash from operations / revenue.
Effective tax rate22.8%Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)25.1%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)6.2%Net income / average total assets.
R&D / revenue6.7%Research and development expense / revenue.
SG&A / revenue17.6%Selling, general and administrative expense / revenue.
Stock-based pay / revenue0.5%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue4.1%Capital expenditures / revenue.
D&A / revenue5.1%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y-2.1%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y-5.3%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y-6.1%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y1.1%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y-3.8%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y-4.0%Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y28.7%Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y-19.7%Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y-6.7%Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y31.9%EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y-18.1%Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y-5.4%Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y42.5%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y1.3%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y-8.5%Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y232.0%Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y20.7%Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y-7.2%Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y-11.6%Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y-5.1%Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y-1.5%Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y0.1%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y-14.9%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y3.1%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y-2.9%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y-8.5%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y-3.9%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y-2.5%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y-2.0%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y-1.4%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio1.92xCurrent assets / current liabilities.
Quick ratio1.08x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.67x(Cash + short-term investments) / current liabilities.
Debt / equity0.81xTotal debt / shareholders' equity. Not shown when equity is negative.
Debt / assets20.3%Total debt / total assets.
Liabilities / assets74.5%Total liabilities / total assets.
Net debt$2.14BTotal debt - cash - short-term investments. Negative means more cash than debt.
Working capital$8.22BCurrent assets - current liabilities.
Goodwill and intangibles / assets19.6%(Goodwill + intangible assets) / total assets.
Tangible book value$2.15BShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.61xRevenue / average total assets.
Fixed asset turnover2.59xRevenue / average property, plant and equipment.
Inventory turnover2.45xCost of revenue / average inventory.
Days inventory149 days365 x average inventory / cost of revenue.
Receivables turnover6.98xRevenue / average receivables.
Days sales outstanding52 days365 x average receivables / revenue.
Days payables90 days365 x average accounts payable / cost of revenue.
Cash conversion cycle112 daysDays inventory + days sales outstanding - days payables.
FCF conversion90.8%Free cash flow / net income, when net income is positive.
Capex / operating cash flow30.9%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted$2.85Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic$2.87Net income per basic share, as reported (split-adjusted).
Revenue per share$28.04Revenue / diluted weighted shares.
FCF per share$2.60Free cash flow / diluted weighted shares.
Operating cash flow per share$3.76Cash from operations / diluted weighted shares.
Book value per share$11.40Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share$2.46Tangible book value / shares outstanding.
Cash per share$6.80(Cash + short-term investments) / shares outstanding.
Dividend per share$1.52Dividend declared per common share (paid, when declared is not tagged).
Payout ratio53.1%Dividends paid / net income, when net income is positive.
Dividends / FCF58.5%Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF40.2%Share buybacks / free cash flow, when free cash flow is positive.

Valuation

MetricValueHow it is calculated
Market cap$5.1KShare price x shares outstanding.
Enterprise value$2.14BMarket cap + total debt - cash - short-term investments.
P/E0.00xMarket cap / net income. Only when net income is positive.
P/S0.00xMarket cap / revenue.
P/B0.00xMarket cap / shareholders' equity. Only when equity is positive.
Price / tangible book0.00xMarket cap / tangible book value, when positive.
P/FCF0.00xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF0.00xMarket cap / cash from operations, when positive.
EV/Sales0.09xEnterprise value / revenue.
EV/FCF0.94xEnterprise value / free cash flow, when both are positive.
FCF yield45,132,568.0%Free cash flow / market cap.
Earnings yield49,722,992.0%Net income / market cap (the inverse of P/E).
Dividend yield26,414,721.0%Dividends paid over the period / market cap.
Shareholder yield44,538,979.0%(Dividends paid + share buybacks) / market cap.
What was EIDP, Inc.'s revenue in fiscal 2016?

EIDP, Inc. reported revenue of $24.59B for fiscal 2016, 2.1% lower than the year before.

Was EIDP, Inc. profitable in fiscal 2016?

Yes. Net income was $2.51B, a net margin of 10.2%.

How much free cash flow did EIDP, Inc. generate in fiscal 2016?

Cash from operations of $3.30B minus capital expenditures of $1.02B left free cash flow of $2.28B.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to EIDP, Inc.